You are here
Beginning in November, Stater Bros. Super Rx Pharmacies in Southern California will offer seven diabetes medications free of charge.
“Stater Bros. has a long-standing history of giving back to the communities it serves, and we believe in doing the right thing for the right reason,” said Jack H. Brown, Stater Bros. chairman and CEO. “To provide these medications for free during these tough economic times is the right thing to do. We’re pleased to be able to provide our valued customers with access to high quality, affordable pharmacy services.”
The medications, in varying strengths and up to 100 pills, will be offered for free beginning Nov. 1, the first day of National Diabetes Awareness Month. To participate in this program, customers must have a valid prescription from their doctor. All transferred and authorized refills are included as prescribed by a physician. No membership or other type of commitment is required.
Included medications are Metformin, Metformin ER, Glimepride, Glipizide, Glipizide XL, Glyburide and Glyburide Micro.
Stater Bros. Super Rx Pharmacy features healthy living programs including a free antibiotic program that offers a 14-day supply of selected antibiotics, including refills, at no charge to anyone with or without health insurance coverage who presents a prescription. Stater Bros. has also introduced a $4 generic prescription program; more than 300 commonly prescribed medications are $4 for a 30-day supply or $10 for a 90-day supply.
According to the American Diabetes Association, total costs of diagnosed diabetes in the United States in 2007 were estimated at $174 billion. Millions of Americans have been diagnosed with type II diabetes and many more are unaware that they are at risk or in fact living with the disease. Individuals with type II diabetes use pills to manage their diabetes and these medications can be costly.
Founded in 1936 in Yucaipa, Calif., Stater Bros. Supermarkets is the largest privately owned supermarket chain in Southern California with 167 markets and annual sales in 2009 of $3.77 billion.